Balchem Corporation announced its participation in the BNP Paribas Exane Consumer Ingredients & Chemicals Conference on March 11, 2026, with senior executives including CEO Ted Harris, CFO Martin Bengtsson, and Senior Director of Investor Relations Allison Baurichter attending. The company also plans to participate in the JP Morgan Consumer Ingredients Forum on March 10, 2026.

Balchem Corporation announced a conference call scheduled for February 20, 2026, at 11:00 AM ET to discuss fourth quarter and full year 2025 financial results. The call will be hosted by CEO Ted Harris and CFO Martin Bengtsson, with results to be published prior to market opening. The company also noted attendance at the CJS Securities 26th Annual New Ideas for the New Year Virtual Conference on January 14, 2026.

The European Union has implemented anti-dumping duties of 90.0-115.9% on choline chloride imports from China, effective for five years. EU producers Eastman and Balchem welcome the decision, citing protection of European jobs, supply chain security, and fair trade practices. The EU also clarified customs origin rules to prevent circumvention through transshipment via third countries.

Balchem director David B. Fischer sold 8,000 shares for $1.2 million, reducing his direct holdings by 50%. The sale occurred a week before the company announced a 10.3% dividend increase and reported record quarterly sales growth.

Balchem Corporation declared a quarterly dividend of $0.96 per share, representing a 10.3% increase from the previous year. This marks the company's seventeenth consecutive annual dividend increase, reflecting strong financial performance and confidence in long-term strategies.

Balchem Corporation will present at the H.C. Wainwright 27th Annual Global Investment Conference on September 9, 2025, with key executives including Ted Harris, Martin Bengtsson, and Allison Baurichter.

Balchem reported strong Q2 2025 financial performance, with 9.1% revenue growth to $255.5 million, non-GAAP EPS of $1.27, and strategic investments in micro-encapsulation technologies. All business segments showed growth, and the company benefited from favorable EU trade regulations.

Balchem Corporation will host a conference call on July 31, 2025, at 11:00 AM ET to review second quarter 2025 financial results, with CEO Ted Harris and CFO Martin Bengtsson presenting.

The global magnesium supplements market is projected to grow from USD 4.37 billion in 2024 to USD 8.94 billion by 2034, with a 7.43% CAGR, driven by increasing health awareness, clean-label products, and personalized nutrition trends.

Balchem Corporation, a global specialty ingredient manufacturer, announced they will present at the Wells Fargo Industrials and Materials Conference on June 11, 2025. The company operates in three business segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products.

Balchem Corporation announced that it will hold a conference call on April 24, 2025, to discuss its first quarter 2025 financial results. The company operates in the human nutrition, animal nutrition, and specialty products industries.

Balchem Corporation reported record fourth quarter and full year 2024 results, with strong growth in net sales, adjusted EBITDA, and free cash flow across its three business segments.